Core Viewpoint - The company, Yipai Yangguang (02522), has announced a share placement to raise approximately HKD 562 million, with a discount of about 12.53%, to fund its development in data and artificial intelligence, as well as to expand its medical imaging business [1] Group 1: Share Placement and Fund Allocation - Yipai Yangguang plans to place 35 million shares at a discount of approximately 12.53%, aiming to raise net proceeds of about HKD 562 million [1] - Approximately 40% of the net proceeds will be allocated to the development of data and AI capabilities, focusing on medical imaging data mining, annotation, and cleaning services [1] - About 30% of the net proceeds will be used for expanding the company's medical imaging center business and enabling solution services through self-investment or acquisitions, targeting both domestic and overseas markets, including Hong Kong and Singapore [1] Group 2: Financial Performance - For the six months ending June 30, 2025, the company reported revenue of RMB 467 million, representing a year-on-year increase of 12.89% [1] - Gross profit was reported at RMB 137 million, with a significant increase in net profit attributable to shareholders of RMB 16.44 million, up 328.65% year-on-year [1] - The company anticipates that its newly established imaging center projects will gradually commence operations in the second half of 2025, benefiting from the ongoing release of national medical infrastructure policies [1]
港股异动 | 一脉阳光(02522)涨超5% 拟配股加码医学影像AI与市场扩张 料影像中心项目于年内交付投入运营